User menu

Cognitive deficits in patients with multiple sclerosis

Bibliographic reference Marshall, ID ; Sindic, Christian ; McKercher, CE ; Wesnes, KA ; Tinbergen, J ; et. al. Cognitive deficits in patients with multiple sclerosis.Summer Meeting of the British-Association-for-Psychopharmacology (Harrogate (England), Jul 25-28, 2004). In: Journal of Psychopharmacology, Vol. 18, no. 3, p. A54-A54 (2004)
Permanent URL http://hdl.handle.net/2078.1/61412
  1. Corchero Javier, Romero Julian, Berrendero Fernando, Fernandez-Ruiz Javier, Ramos José A., Fuentes José A., Manzanares Jorge, Time-dependent differences of repeated administration with Δ9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ-opioid and CB1-cannabinoid receptors in the caudate–putamen, 10.1016/s0169-328x(99)00053-4
  2. Fan G H, Wang L Z, Qiu H C, Ma L, Pei G (1999) Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence . Mol Pharmacol 56: 39–45
  3. Fride E., Endocannabinoids in the central nervous system-an overview, 10.1054/plef.2001.0360
  4. Hine Bromfield, Torrelio Marina, Gershon Samuel, Interactions between cannabidiol and Δ9-THC during abstinence in morphine-dependent rats, 10.1016/0024-3205(75)90435-x
  5. Kaymak�alan ?�kr�, Ayhan I. Hakki, Tulunay F. Cankat, Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats, 10.1007/bf00497855
  6. Lu Lin, Zeng Shaoshu, Liu Dehong, Ceng Xiaobo, Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats, 10.1016/s0304-3940(00)01352-5
  7. Mansour A, Khachaturian H, Lewis M E, Akil H, Watson S J (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain . J Neurosci 7: 2445–2464
  8. Manzanares Jorge, Corchero Javier, Romero Julian, Fernández-Ruiz Javier J., Ramos José A., Fuentes José A., Pharmacological and biochemical interactions between opioids and cannabinoids, 10.1016/s0165-6147(99)01339-5
  9. Martellotta M.C., Cossu G., Fattore L., Gessa G.L., Fratta W., Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice, 10.1016/s0306-4522(98)00052-9
  10. Martin William J, Coffin Phillip O, Attias Edna, Balinsky Melissa, Tsou Kang, Walker J.Michael, Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections, 10.1016/s0006-8993(98)01368-7
  11. Meng Ian D., Manning Barton H., Martin William J., Fields Howard L., 10.1038/26481
  12. Navarro M, Carrera M R, Fratta W, Valverde O, Cossu G, Fattore L, Chowen J A, Gomez R, del Arco I, Villanua M A, Maldonado R, Koob G F, de Fonseca F R (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration . J Neurosci 21: 5344–5350
  13. Rodriguez J J, Mackie K, Pickel V M (2001) Ultrastructural localization of the CB1 cannabinoid receptor in µ-opioid receptor patches of the rat caudate putamen nucleus . J Neurosci 21: 823–833
  14. Salio Chiara, Fischer Jacqueline, Franzoni Maria Fosca, Mackie Ken, Kaneko Takeshi, Conrath Marie, CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn : , 10.1097/00001756-200112040-00017
  15. Vela G., Ruiz-gayo M., Fuentes J.A., Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine, 10.1016/0028-3908(95)00032-2
  16. Vela Gema, Fuentes Jose´A., Bonnin Ana, Ferna´ndez-Ruiz Javier, Ruiz-Gayo Mariano, Perinatal exposure toΔ9-tetrahydrocannabinol (Δ9-THC) leads to changes in opioid-related behavioral patterns in rats, 10.1016/0006-8993(95)00255-o
  17. Walker J. M., Huang S. M., Strangman N. M., Tsou K., Sanudo-Pena M. C., Pain modulation by release of the endogenous cannabinoid anandamide, 10.1073/pnas.96.21.12198
  18. Walker J.Michael, Hohmann Andrea G., Martin William J., Strangman Nicole M., Huang Susan M., Tsou Kang, The neurobiology of cannabinoid analgesia, 10.1016/s0024-3205(99)00289-1